A prudent path forward for genomic engineering and germline gene modification

Cited by (733)

Items 701–733 of 733

1. CRISPR-Cas9 Technology for Combating Genetic Disorders
   Ajay Kumar Sharma, Pratibha Singh · 2026 · IGI Global eBooks
2. CRISPR-Cas9 Technology for Unlocking Immunity Against Infectious Pathogens
   M. Suriya, V. Aarthi, Setti Sudharsan Meenambiga, P. Ravi Prakash, P. Vivek · 2026 · IGI Global eBooks
3. Targeted pinpoint gene editing tool, CRISPR/Cas9: A Review
   Hafsa Tahir, Rashid Saif, Talha Tamseel, Fraz Ahmad · 2018 · International Journal of Biosciences (IJB)
4. CRISPR-Based Synthetic Gene Circuits for Industrial and Therapeutic Applications
   Jonna M. Raue · 2024 · Academic International Journal of Engineering Science
5. The Path to Resolving the Ethical Dilemma of Gene Editing Technology and Strategies for Enhancing Social Acceptance
   MingQing Li · 2026 · International Journal of Social Sciences and Public Administration
6. An Outlook of CRISPR-Mediated Gene Editing in Wheat
   Veysel Süzerer, Selin Gül Ünsal, Engin Tilkat · 2026 · Sustainability Sciences in Asia and Africa
7. Transformasi Ilmu Hayati melalui Pendekatan Bioteknologi Modern
   Marsahip Marsahip · 2025 · JURNAL RISET RUMPUN MATEMATIKA DAN ILMU PENGETAHUAN ALAM
8. The Conditions for Trust in Science, Technology and Innovation
   Maria Michali, Amalia Kallergi, Eva Paraschou, Laurens Landeweerd, Steffi Friedrichs, Athena I. Vakali, George Gaskell · 2026 · SpringerBriefs in research and innovation governance
9. Single-cell transcriptomics reveals a spermatogonial stem cell-centered spermatogenic microenvironment: Pathophysiological mechanisms and therapeutic targets in male infertility
   Zhi-Kang Ying, Xin-Yu Xu, Jiawei Hu, Yun Cui, Da-Wei Jiang · 2026 · World Journal of Stem Cells
10. Forks in the road: Françoise Baylis on ethics, genome editing, and the world we want to live in
    Ping Yan, Lu Gao · 2026 · Cultures of Science
11. Rechtliche Herausforderungen moderner Verfahren der Intervention in die menschliche Keimbahn : ein deutsch-französischer Rechtsvergleich zum Einsatz von CRISPR/Cas9 und hiPS-Zellen sowie zum Mitochondrientransfer
    Silvia Deuring · 2019 · theses.fr (ABES)
12. Evolution of approaches to manipulating the genetic material of living objects: from selection to genome editing
    D. V. Stambolsky, A. V. Zakharova, Maxim N. Karagyaur · 2026 · Регенерация органов и тканей.
13. L’ingouvernable à l’âge de l'édition du génome : une analyse comparée des politiques des nucléases en Europe, aux États-Unis et en Chine
    Guillaume Levrier · 2022 · theses.fr (ABES)
14. CRISPR-Cas Systems: Mechanisms, Variants, and Biomedical Applications: A Comprehensive Review
    Augustine Chinedu Ihim, Kelechi Caroline Obi, Patrick Chinedu Obi, Ini Edeh, Donatus F.N. Ozuruoke, Tochukwu Anthony Ikwelle · 2026 · Journal of Drug Delivery and Therapeutics
15. Cellular reprogramming for reverse aging
    Pradeep Kumar Mishra, Shampa Ghosh, Dr. Krishna Kumar Singh, Jitendra Kumar Sinha · 2026 · Elsevier eBooks
16. CRISPR governance at the nexus of public health and national security: Priority setting and risk calculus in Turkey’s emerging bioeconomy
    Z. Durmuş · 2026 · Euchembioj Reviews
17. Prospects of the application of the CRISPR/CAS9 method in fundamental advanced research, diagnostics and therapies of socially significant illness in children and adolescents in Ukraine
    О. В. Боброва, N. Н. Mikhanovska, Krystyna A. Kryvonos · 2024 · Children and adolescents health care
18. Ethics of Genetic Engineering and Gene Editing in Humans
    Salim Dakhil Rashid Rashid, Ahmed Rashid Tubena, Sabah Attwan Kazi · 2026 · Jurnal MIPA dan Pembelajarannya
19. CRISPR/Cas9 and the Legitimacy of Nontherapeutic Genetic Intervention
    José Tomás Alvarado, Paulo López-Soto, Alex J. Wolf, Manuel J. Santos · 2026 · New paradigms in healthcare
20. Induced Pluripotent Stem Cells and Gene Editing: A Transformative Era in Regenerative Medicine
    Sujitha Mathivanan, Balaji A, Syed Mohamed Omar S, Harish Babu, Sujan S, Thilan D · 2026 · International Journal of Drug Delivery Technology
21. New genomic techniques for sustainable agriculture and their prospects in Europe
    George Gaskell, Agnes Allansdottir, Jürgen Hampel, Nicole Kronberger, Gemma Revuelta, Helge Torgersen · 2026 · npj Sustainable Agriculture
22. CRISPR-Cas9 et IA : deux paradigmes gémellaires. Discours en l’honneur de deux lauréats du prix Nobel élevés à la dignité de docteurs honoris causa de l’Académie nationale de médecine
    Pierre Le Coz · 2026 · Bulletin de l Académie Nationale de Médecine
23. Genome Editing Using Crispr-Cas9 for Genetic Engineering and Nanozyme Technology: A Review
    Israel O Modamori, Taiwo Stephen Okanlawon, J. O. Ebhomienlen, M. O. Otun, G. C. Unogwa, Badmus A. A · 2025 · Biological and Environmental Sciences Journal for the Tropics
24. Stop, Collaborate, and Listen: A Thematic Analysis of Life Scientists’ Calls for Research Moratoria
    Christopher Alan Bobier, Daniel J. Hurst · 2026 · Applied Biosafety
25. The Bioconservative Stance within Bioethics
    Edward Hockings · 2026 · The New Bioethics
26. AI-Integrated Data Analytics for Strategic Decision Intelligence in Biotechnologies: A Human-Centered Framework Across Biomanufacturing, Gene Technologies, And Medical Countermeasures
    Naresh Gumala · 2026 · SSRN Electronic Journal
27. Recent Advances in CRISPR/Cas Technologies for Biological Discovery, Therapeutics, and Diagnostics
    Moon‐Soo Kim, Hae Sol Do, Hye Yeon Jang, Kang Eun Lee, Sun Ju Lee · 2026 · Biomolecules
28. Genetherapy in neurological disorders
    Victor Bushlyar, Bhaskar Roy, Atri Chatterjee · 2026 · Elsevier eBooks
29. Making and Knowing: On the Alleged First Principles of Bioscience and Biotechnology
    Kao-Cheng Huang · 2026 · London Journal of Research In Humanities and Social Sciences
30. CRISPR and gene editing approaches in prostate cancer: Clinical applications and therapeutic potential
    Vaibhavkumar Patel, Pratichi Singh, Sthiti Porna Dutta, Sonal Pande, Rica Langstang, Aarti Kushwaha · 2026 · Critical Reviews in Oncology/Hematology
31. BETWEEN THE CHILD WISH AND CHILDREN’S RIGHTS IN EUROPEAN GLOBALIZED GAMETE DONATION: FROM DIVERGENT TO CONVERGENT REGULATORY MODELS
    Елена Игновска · 2026 · Iustinianus Primus Law Review
32. The Genomic Equity Accessibility Framework (GEAF): A dimensionally consistent framework for modeling affordability and equity in genomic and regenerative therapies
    Peter Oloche David · 2026 · PLoS ONE
33. Has it been a crime or should it be criminalised? A case study on genome-edited babies and the improvement of criminal statutes in China
    Dan Yang · 2026 · Humanities and Social Sciences Communications